Full Press Release Details
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased NRx Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition Corp.) ("NRXP" or the "Company") (NASDAQ: NRXP) stock prior to May 24, 2021 and still hold such stock.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of NRXP's 2021 de-SPAC merger. Shortly after the NRXP 2021 de-SPAC merger closed, NRXP stock began spiraling downwards.
To learn more about the action and your rights, go to:
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.
The NRXP de-SPAC merger investigation concerns whether this transaction unfairly harmed stockholders and whether all material facts were properly disclosed to stockholders.
Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington, D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, Suite #427